Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Kiessling

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Drug Discovery Today. Technologies|December 17, 2016
Translational immunotoxicology of immunomodulatory monoclonal antibodiesFrank R Brennan, Andrea Kiessling
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 7, 2017
In vitro assays supporting the safety assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Andrea Kiessling
Cancer Letters|July 28, 2005
Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissuesAna C Cunha, Bernd Weigle, Andrea Kiessling, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Cytokine|August 8, 2013
Response to the letter to the editor by Susan Thorpe et al.: how predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of responseBabette Wolf, Hannah Morgan, Frank Brennan, et al.
European Urology|December 7, 2007
Advances in specific immunotherapy for prostate cancerAndrea Kiessling, Susanne Füssel, Rebekka Wehner, et al.
Biochemical and Biophysical Research Communications|January 15, 2005
Increased p21(ras) activity in human fibroblasts transduced with survivin enhances cell proliferationAchim Temme, Petra Diestelkoetter-Bachert, Marc Schmitz, et al.
Cancer Letters|March 1, 2006
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11Marc Schmitz, Rebekka Wehner, Stefan Stevanovic, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Drug Discovery Today. Technologies|December 17, 2016
Translational immunotoxicology of immunomodulatory monoclonal antibodiesFrank R Brennan, Andrea Kiessling
Toxicology in Vitro : an International Journal Published in Association with BIBRA|March 7, 2017
In vitro assays supporting the safety assessment of immunomodulatory monoclonal antibodiesFrank R Brennan, Andrea Kiessling
Cancer Letters|July 28, 2005
Tissue-specificity of prostate specific antigens: comparative analysis of transcript levels in prostate and non-prostatic tissuesAna C Cunha, Bernd Weigle, Andrea Kiessling, et al.
Cancers|November 12, 2013
Tumor-associated antigens for specific immunotherapy of prostate cancerAndrea Kiessling, Rebekka Wehner, Susanne Füssel, et al.
Cytokine|August 8, 2013
Response to the letter to the editor by Susan Thorpe et al.: how predictive are in vitro assays for cytokine release syndrome in vivo? A comparison of methods reveals worrying differences in sensitivity and frequency of responseBabette Wolf, Hannah Morgan, Frank Brennan, et al.
European Urology|December 7, 2007
Advances in specific immunotherapy for prostate cancerAndrea Kiessling, Susanne Füssel, Rebekka Wehner, et al.
Biochemical and Biophysical Research Communications|January 15, 2005
Increased p21(ras) activity in human fibroblasts transduced with survivin enhances cell proliferationAchim Temme, Petra Diestelkoetter-Bachert, Marc Schmitz, et al.
Cancer Letters|March 1, 2006
Identification of a naturally processed T cell epitope derived from the glioma-associated protein SOX11Marc Schmitz, Rebekka Wehner, Stefan Stevanovic, et al.
The Prostate|July 15, 2003
Identification of an HLA-A*0201-restricted T-cell epitope derived from the prostate cancer-associated protein trp-p8Andrea Kiessling, Susanne Füssel, Marc Schmitz, et al.
Clinical & Developmental Immunology|November 16, 2010
Dendritic cell-based immunotherapy for prostate cancerHanka Jähnisch, Susanne Füssel, Andrea Kiessling, et al.
Pageof 4